BRAF and colorectal carcinoma: Taken together, our findings support the notion that BRAF-mutated colorectal tumors favor a strong immune activated state enriched with antigen-presenting cells and T lymphocytes, and therefore associates with MSI-H and CSM1 CRC tumors.